457 related articles for article (PubMed ID: 16125044)
1. beta-Agonist tocolytic therapy.
Lam F; Gill P
Obstet Gynecol Clin North Am; 2005 Sep; 32(3):457-84. PubMed ID: 16125044
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
Wenstrom KD; Weiner CP; Merrill D; Niebyl J
Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
[TBL] [Abstract][Full Text] [Related]
3. Arg16 homozygosity of the beta2-adrenergic receptor improves the outcome after beta2-agonist tocolysis for preterm labor.
Landau R; Morales MA; Antonarakis SE; Blouin JL; Smiley RM
Clin Pharmacol Ther; 2005 Dec; 78(6):656-63. PubMed ID: 16338281
[TBL] [Abstract][Full Text] [Related]
4. Subcutaneous tocolytic infusion therapy for patients at very high risk for preterm birth.
Allbert JR; Wise CA; Lou CH; Gookin KS; Parmenter MA; Morrison JC
J Perinatol; 1992 Mar; 12(1):28-31. PubMed ID: 1348530
[TBL] [Abstract][Full Text] [Related]
5. Clinical issues surrounding the use of terbutaline sulfate for preterm labor.
Lam F; Elliott J; Jones JS; Katz M; Knuppel RA; Morrison J; Newman R; Phelan J; Willcourt R
Obstet Gynecol Surv; 1998 Nov; 53(11 Suppl):S85-95. PubMed ID: 9812326
[TBL] [Abstract][Full Text] [Related]
6. Parotitis due to ritodrine tocolytic treatment for preterm labor.
Marioni G; Marchese-Ragona R; Ottaviano G; Campobasso C; Staffieri A
Otolaryngol Head Neck Surg; 2005 Apr; 132(4):665-6. PubMed ID: 15806068
[No Abstract] [Full Text] [Related]
7. Are oral betamimetics effective maintenance therapies after threatened preterm labor?
Griffin G
Am Fam Physician; 2007 Mar; 75(5):648-9. PubMed ID: 17375508
[No Abstract] [Full Text] [Related]
8. [Treatment of preterm labor with ritodrine].
Zhu B; Fu Y
Zhonghua Fu Chan Ke Za Zhi; 1996 Dec; 31(12):721-3. PubMed ID: 9387512
[TBL] [Abstract][Full Text] [Related]
9. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
10. [Nifedipine first choice in management of threatening preterm labor].
Papatsonis DN; Timmerman CC; Oei SG; van Geijn HP
Ned Tijdschr Geneeskd; 2002 Oct; 146(42):1980-3. PubMed ID: 12420423
[TBL] [Abstract][Full Text] [Related]
11. [Tocolysis, use of beta-sympatomimetics for threatening preterm delivery: a critical review].
Rozenberg P
J Gynecol Obstet Biol Reprod (Paris); 2001 May; 30(3):221-30. PubMed ID: 11397997
[TBL] [Abstract][Full Text] [Related]
12. [Medical tocolysis in threatening premature labor: what is safe in therapy?].
Grospietsch G
Gynakologe; 1991 Aug; 24(4):188-97. PubMed ID: 1682223
[No Abstract] [Full Text] [Related]
13. Magnesium sulfate and beta-mimetic dual-agent tocolysis in preterm labor after single-agent failure.
Ogburn PL; Hansen CA; Williams PP; Butler JC; Joseph MS; Julian TM
J Reprod Med; 1985 Aug; 30(8):583-7. PubMed ID: 2864441
[TBL] [Abstract][Full Text] [Related]
14. What's new in tocolytics.
Leonardi MR; Hankins GD
Clin Perinatol; 1992 Jun; 19(2):367-84. PubMed ID: 1352193
[TBL] [Abstract][Full Text] [Related]
15. Terbutaline by pump to prevent recurrent preterm labor.
Gill P; Smith M; McGregor C
MCN Am J Matern Child Nurs; 1989; 14(3):163-7. PubMed ID: 2498593
[No Abstract] [Full Text] [Related]
16. 'Normal' pregnancy with adverse events on initial tocolytic treatment.
Dudenhausen J
BJOG; 2006 Dec; 113 Suppl 3():116-7. PubMed ID: 17206979
[TBL] [Abstract][Full Text] [Related]
17. Rebound hyperkalemia after cessation of intravenous tocolytic therapy with terbutaline in the treatment of preterm labor: anesthetic implications.
Kuczkowski KM; Benumof JL
J Clin Anesth; 2003 Aug; 15(5):357-8. PubMed ID: 14507561
[TBL] [Abstract][Full Text] [Related]
18. [Tocolysis with the beta-adrenomimetic Partusisten in premature labor].
Ivanov S
Akush Ginekol (Sofiia); 1997; 36(2):9-10. PubMed ID: 9471910
[TBL] [Abstract][Full Text] [Related]
19. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy.
Elliott JP; Istwan NB; Rhea D; Stanziano G
Am J Obstet Gynecol; 2004 Oct; 191(4):1277-82. PubMed ID: 15507953
[TBL] [Abstract][Full Text] [Related]
20. [Nutri-mag--right of choice for magnesium tocolytic therapy].
Nalbanski B; Pavlova E; Karamisheva B
Akush Ginekol (Sofiia); 2009; 48 Suppl 2():12-5. PubMed ID: 20380090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
